Trial Profile
Multicenter Randomized Controlled Trial Comparing Legflow - DCB (Cardionovum) Versus Bare Balloon Angioplasty for the Treatment of Atherosclerotic Disease in the Superficial Femoral & Popliteal Segment
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Jan 2020
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Atherosclerosis
- Focus Therapeutic Use
- Sponsors Cardionovum
- 22 Jan 2020 Status changed from recruiting to completed.
- 04 Aug 2019 Planned primary completion date changed from 1 Aug 2019 to 1 Oct 2019.
- 16 Jul 2018 Planned End Date changed from 1 Jul 2019 to 1 Oct 2019.